Nichols & Pratt Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Buy |
29,202
+1,442
| +5% | +$585K | 0.79% | 32 |
|
|
2025
Q1 | $13.8M | Buy |
27,760
+2,852
| +11% | +$1.42M | 0.94% | 31 |
|
|
2024
Q4 | $13M | Buy |
24,908
+2,283
| +10% | +$1.19M | 0.86% | 30 |
|
|
2024
Q3 | $14M | Buy |
22,625
+2,102
| +10% | +$1.3M | 0.9% | 31 |
|
|
2024
Q2 | $11.3M | Buy |
20,523
+1,434
| +8% | +$793K | 0.77% | 32 |
|
|
2024
Q1 | $11.1M | Buy |
19,089
+1,763
| +10% | +$1.02M | 0.75% | 32 |
|
|
2023
Q4 | $9.2M | Buy |
17,326
+7,435
| +75% | +$3.95M | 0.65% | 33 |
|
|
2023
Q3 | $5.01M | Buy |
9,891
+9,267
| +1,485% | +$4.69M | 0.38% | 38 |
|
|
2023
Q2 | $326K | Buy |
+624
| New | +$326K | 0.02% | 90 |
|